United States

VolitionRX Ltd (VNRX)

Track

Track

Ticker: VNRX Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for VolitionRX Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.9
Eight Corp Ltd Large shareholder
Transaction date
Sale
Price
297.54
Quantity 64,544 -16.8%
Value US$2,747,324
1.9
Eight Corp Ltd Large shareholder
Transaction date
Sale
Price
493.01
Quantity 83,809 +49.1%
Value US$4,904,977
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
87.06
Quantity 92,949 -47.1%
Value US$4,883,606
1.7
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
3.47
Quantity 50,000 +3.4%
Value US$173,500
2.3
Nguyen Kim Non-Executive Director
Transaction date
Purchase
Price
3.20
Quantity 2,000 +400.0%
Value US$6,400
1.7
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
3.29
Quantity 100,000 +7.2%
Value US$329,000
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
5.37
Quantity 10,000 -22.2%
Value US$53,700
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
3.40
Quantity 10,000 -18.2%
Value US$34,000
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
3.45
Quantity 200 -0.4%
Value US$690
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
3.35
Quantity 3,229 -5.5%
Value US$10,817
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
3.40
Quantity 1,571 -2.6%
Value US$5,341
2.8
TERRELL JASON BRADLEY MD Chief Medical Officer Officer
Transaction date
Sale
Price
3.23
Quantity 19,500 -35.8%
Value US$62,985
2.7
Faulkes Martin Charles Non-Executive Director
Transaction date
Sale
Price
3.21
Quantity 65,000 -4.1%
Value US$208,650
Reynolds Cameron John President and CEO Executive Director
Transaction date
Purchase
Price
2.75
Quantity 4,000 +0.4%
Value US$11,000
Reynolds Cameron John President and CEO Executive Director
Transaction date
Purchase
Price
4.24
Quantity 1,100 +0.1%
Value US$4,664
1.9
Eight Corp Ltd Large shareholder
Transaction date
Purchase
Price
5.69
Quantity 50,000 +0.4%
Value US$284,570
1.9
Eight Corp Ltd Large shareholder
Transaction date
Sale
Price
6.03
Quantity 46,238 -0.4%
Value US$278,792
Faulkes Martin Charles Non-Executive Director
Transaction date
Purchase
Price
3.75
Quantity 10,000 +0.6%
Value US$37,500
Faulkes Martin Charles Non-Executive Director
Transaction date
Purchase
Price
3.94
Quantity 50,000 +3.3%
Value US$197,000
2.7
Faulkes Martin Charles
Transaction date
Purchase
Price
3.14
Quantity 10,000 +0.7%
Value US$31,400
2.7
Faulkes Martin Charles
Transaction date
Purchase
Price
3.10
Quantity 69,269 +4.9%
Value US$214,734
2.7
Faulkes Martin Charles
Transaction date
Purchase
Price
3.02
Quantity 70,731 +5.2%
Value US$213,608
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
2.00
Quantity 49,826 +3.8%
Value US$99,652
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
1.99
Quantity 14 +0.0%
Value US$28
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
1.97
Quantity 7 +0.0%
Value US$14
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
1.95
Quantity 153 +0.0%
Value US$298
Rootsaert Rodney Gerard Secretary Officer
Transaction date
Purchase
Price
1.91
Quantity 5,000 +103.6%
Value US$9,550
Reynolds Cameron John President and CEO Executive Director
Transaction date
Purchase
Price
1.91
Quantity 6,500 +0.6%
Value US$12,415
Vanston David Cecil CHIEF FINANCIAL OFFICER
Transaction date
Purchase
Price
2.84
Quantity 2,750 +inf%
Value US$7,810
Reynolds Cameron John President and CEO Executive Director
Transaction date
Purchase
Price
2.77
Quantity 3,630 +0.4%
Value US$10,055
Rootsaert Rodney Gerard Secretary
Transaction date
Purchase
Price
2.77
Quantity 3,630 +0.4%
Value US$10,055
KRATOCHVIL DAVID MATTHEW Chief Financial Officer Officer
Transaction date
Purchase
Price
5.00
Quantity 10,000 +inf%
Value US$50,000
Reynolds Cameron John President and CEO Executive Director
Transaction date
Sale
Price
3.54
Quantity 3,390 -10.5%
Value US$12,001
Reynolds Cameron John President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.41
Quantity 100 +0.0%
Value US$341
Reynolds Cameron John President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.32
Quantity 1,400 +0.1%
Value US$4,648
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
3.75
Quantity 50,000 +4.5%
Value US$187,500
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
18,748.40
Quantity 8,522 +0.8%
Value US$159,773,865
Colman Alan Non-Executive Director
Transaction date
Purchase
Price
7,000.00
Quantity 3,182 +6.3%
Value US$22,274,000
Faulkes Martin Charles Non-Executive Director
Transaction date
Purchase
Price
2.16
Quantity 5,000 +0.5%
Value US$10,800
Rootsaert Rodney Gerard Secretary Officer
Transaction date
Sale
Price
1.80
Quantity 6,000 -0.6%
Value US$10,800
Rootsaert Rodney Gerard Secretary Officer
Transaction date
Sale
Price
1.80
Quantity 10,000 -0.5%
Value US$18,000
Rootsaert Rodney Gerard Secretary Officer
Transaction date
Sale
Price
1.80
Quantity 12,000 -0.6%
Value US$21,600
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
4,206.72
Quantity 3,572 +0.3%
Value US$15,026,404
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
45,793.28
Quantity 38,884 +3.6%
Value US$1,780,625,900
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
9,999.90
Quantity 4,878 +0.5%
Value US$48,779,512
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
271,102.70
Quantity 132,246 +14.2%
Value US$35,852,247,664
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
1,898.10
Quantity 999 +0.1%
Value US$1,896,202
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
7,951.14
Quantity 4,878 +0.5%
Value US$38,785,661
Innes Guy Archibald Non-Executive Director
Transaction date
Purchase
Price
114,583.22
Quantity 57,292 +6.6%
Value US$6,564,701,840
THACHUK MARY ANNE Secretary Treasurer Officer
Transaction date
Purchase
Price
0.05
Quantity 20,000 +inf%
Value US$1,000
THACHUK E DEL CEO and President Executive Director
Transaction date
Purchase
Price
0.05
Quantity 100,000 +inf%
Value US$5,000
Brooke Brian Gordon Chief Financial Officer Executive Director
Transaction date
Purchase
Price
0.05
Quantity 50,000 +inf%
Value US$2,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-03 2024-01-02 S Sale
1.9
Eight Corp Ltd
Large shareholder
64,544 -16.8%
297.54
US$2,747,324 		64,544 -16.8% 297.54 US$2,747,324
2023-12-20 2023-12-15 S Sale
1.9
Eight Corp Ltd
Large shareholder
83,809 +49.1%
493.01
US$4,904,977 		83,809 +49.1% 493.01 US$4,904,977
2021-06-02 2021-05-28 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
92,949 -47.1%
87.06
US$4,883,606 		92,949 -47.1% 87.06 US$4,883,606
2021-05-18 2021-05-17 B Purchase
1.7
Innes Guy Archibald
Non-Executive Director
50,000 +3.4%
3.47
US$173,500 		50,000 +3.4% 3.47 US$173,500
2021-05-18 2021-05-14 B Purchase
2.3
Nguyen Kim
Non-Executive Director
2,000 +400.0%
3.20
US$6,400 		2,000 +400.0% 3.20 US$6,400
2021-05-18 2021-05-14 B Purchase
1.7
Innes Guy Archibald
Non-Executive Director
100,000 +7.2%
3.29
US$329,000 		100,000 +7.2% 3.29 US$329,000
2021-02-08 2021-02-05 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
10,000 -22.2%
5.37
US$53,700 		10,000 -22.2% 5.37 US$53,700
2020-12-04 2020-12-02 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
10,000 -18.2%
3.40
US$34,000 		10,000 -18.2% 3.40 US$34,000
2020-11-19 2020-11-18 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
200 -0.4%
3.45
US$690 		200 -0.4% 3.45 US$690
2020-11-19 2020-11-18 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
3,229 -5.5%
3.35
US$10,817 		3,229 -5.5% 3.35 US$10,817
2020-11-19 2020-11-17 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
1,571 -2.6%
3.40
US$5,341 		1,571 -2.6% 3.40 US$5,341
2020-09-18 2020-09-15 S Sale
2.8
TERRELL JASON BRADLEY MD

Chief Medical Officer

Officer
19,500 -35.8%
3.23
US$62,985 		19,500 -35.8% 3.23 US$62,985
2020-09-10 2020-09-09 S Sale
2.7
Faulkes Martin Charles
Non-Executive Director
65,000 -4.1%
3.21
US$208,650 		65,000 -4.1% 3.21 US$208,650
2020-05-22 2020-05-22 B Purchase
Reynolds Cameron John

President and CEO

Executive Director
4,000 +0.4%
2.75
US$11,000 		4,000 +0.4% 2.75 US$11,000
2019-12-06 2019-12-05 B Purchase Reynolds Cameron John

President and CEO

Executive Director
1,100 +0.1%
4.24
US$4,664 		1,100 +0.1% 4.24 US$4,664
2019-10-18 2019-10-01 B Purchase
1.9
Eight Corp Ltd
Large shareholder
50,000 +0.4%
5.69
US$284,570 		50,000 +0.4% 5.69 US$284,570
2019-09-30 2019-09-26 S Sale
1.9
Eight Corp Ltd
Large shareholder
46,238 -0.4%
6.03
US$278,792 		46,238 -0.4% 6.03 US$278,792
2019-08-28 2019-08-27 B Purchase Faulkes Martin Charles Non-Executive Director
10,000 +0.6%
3.75
US$37,500 		10,000 +0.6% 3.75 US$37,500
2019-08-16 2019-08-15 B Purchase Faulkes Martin Charles Non-Executive Director
50,000 +3.3%
3.94
US$197,000 		50,000 +3.3% 3.94 US$197,000
2019-06-13 2019-06-11 B Purchase
2.7
Faulkes Martin Charles
10,000 +0.7%
3.14
US$31,400 		10,000 +0.7% 3.14 US$31,400
2019-06-13 2019-06-11 B Purchase
2.7
Faulkes Martin Charles
69,269 +4.9%
3.10
US$214,734 		69,269 +4.9% 3.10 US$214,734
2019-06-12 2019-06-10 B Purchase
2.7
Faulkes Martin Charles
70,731 +5.2%
3.02
US$213,608 		70,731 +5.2% 3.02 US$213,608
2018-08-20 2018-08-16 B Purchase Innes Guy Archibald Non-Executive Director
49,826 +3.8%
2.00
US$99,652 		49,826 +3.8% 2.00 US$99,652
2018-08-20 2018-08-16 B Purchase Innes Guy Archibald Non-Executive Director
14 +0.0%
1.99
US$28 		14 +0.0% 1.99 US$28
2018-08-20 2018-08-16 B Purchase Innes Guy Archibald Non-Executive Director
7 +0.0%
1.97
US$14 		7 +0.0% 1.97 US$14
2018-08-20 2018-08-16 B Purchase Innes Guy Archibald Non-Executive Director
153 +0.0%
1.95
US$298 		153 +0.0% 1.95 US$298
2018-08-17 2018-08-16 B Purchase Rootsaert Rodney Gerard

Secretary

Officer
5,000 +103.6%
1.91
US$9,550 		5,000 +103.6% 1.91 US$9,550
2018-08-17 2018-08-16 B Purchase Reynolds Cameron John

President and CEO

Executive Director
6,500 +0.6%
1.91
US$12,415 		6,500 +0.6% 1.91 US$12,415
2017-09-19 2017-09-19 B Purchase Vanston David Cecil

CHIEF FINANCIAL OFFICER
2,750 +inf%
2.84
US$7,810 		2,750 +inf% 2.84 US$7,810
2017-08-17 2017-08-16 B Purchase Reynolds Cameron John

President and CEO

Executive Director
3,630 +0.4%
2.77
US$10,055 		3,630 +0.4% 2.77 US$10,055
2017-08-17 2017-08-16 B Purchase Rootsaert Rodney Gerard

Secretary
3,630 +0.4%
2.77
US$10,055 		3,630 +0.4% 2.77 US$10,055
2016-10-06 2016-10-05 B Purchase KRATOCHVIL DAVID MATTHEW

Chief Financial Officer

Officer
10,000 +inf%
5.00
US$50,000 		10,000 +inf% 5.00 US$50,000
2016-05-24 2016-05-20 S Sale Reynolds Cameron John

President and CEO

Executive Director
3,390 -10.5%
3.54
US$12,001 		3,390 -10.5% 3.54 US$12,001
2015-05-18 2015-05-15 B Purchase Reynolds Cameron John

President and CEO

Executive Director Large shareholder
100 +0.0%
3.41
US$341 		100 +0.0% 3.41 US$341
2015-05-18 2015-05-15 B Purchase Reynolds Cameron John

President and CEO

Executive Director Large shareholder
1,400 +0.1%
3.32
US$4,648 		1,400 +0.1% 3.32 US$4,648
2015-02-13 2015-02-11 B Purchase Innes Guy Archibald Non-Executive Director
50,000 +4.5%
3.75
US$187,500 		50,000 +4.5% 3.75 US$187,500
2014-09-29 2014-09-24 B Purchase Innes Guy Archibald Non-Executive Director
8,522 +0.8%
18,748.40
US$159,773,865 		8,522 +0.8% 18,748.40 US$159,773,865
2014-09-29 2014-09-24 B Purchase Colman Alan Non-Executive Director
3,182 +6.3%
7,000.00
US$22,274,000 		3,182 +6.3% 7,000.00 US$22,274,000
2014-09-17 2014-09-15 B Purchase Faulkes Martin Charles Non-Executive Director
5,000 +0.5%
2.16
US$10,800 		5,000 +0.5% 2.16 US$10,800
2014-09-03 2014-09-03 S Sale Rootsaert Rodney Gerard

Secretary

Officer
6,000 -0.6%
1.80
US$10,800 		6,000 -0.6% 1.80 US$10,800
2014-09-03 2014-09-03 S Sale Rootsaert Rodney Gerard

Secretary

Officer
10,000 -0.5%
1.80
US$18,000 		10,000 -0.5% 1.80 US$18,000
2014-09-03 2014-09-03 S Sale Rootsaert Rodney Gerard

Secretary

Officer
12,000 -0.6%
1.80
US$21,600 		12,000 -0.6% 1.80 US$21,600
2014-03-12 2014-03-10 B Purchase Innes Guy Archibald Non-Executive Director
3,572 +0.3%
4,206.72
US$15,026,404 		3,572 +0.3% 4,206.72 US$15,026,404
2014-03-12 2014-03-10 B Purchase Innes Guy Archibald Non-Executive Director
38,884 +3.6%
45,793.28
US$1,780,625,900 		38,884 +3.6% 45,793.28 US$1,780,625,900
2013-12-04 2013-12-02 B Purchase Innes Guy Archibald Non-Executive Director
4,878 +0.5%
9,999.90
US$48,779,512 		4,878 +0.5% 9,999.90 US$48,779,512
2013-12-04 2013-11-25 B Purchase Innes Guy Archibald Non-Executive Director
132,246 +14.2%
271,102.70
US$35,852,247,664 		132,246 +14.2% 271,102.70 US$35,852,247,664
2013-11-18 2013-11-14 B Purchase Innes Guy Archibald Non-Executive Director
999 +0.1%
1,898.10
US$1,896,202 		999 +0.1% 1,898.10 US$1,896,202
2013-11-18 2013-11-14 B Purchase Innes Guy Archibald Non-Executive Director
4,878 +0.5%
7,951.14
US$38,785,661 		4,878 +0.5% 7,951.14 US$38,785,661
2013-11-18 2013-03-25 B Purchase Innes Guy Archibald Non-Executive Director
57,292 +6.6%
114,583.22
US$6,564,701,840 		57,292 +6.6% 114,583.22 US$6,564,701,840
2005-11-28 2005-09-30 B Purchase THACHUK MARY ANNE

Secretary Treasurer

Officer
20,000 +inf%
0.05
US$1,000 		20,000 +inf% 0.05 US$1,000
2005-11-28 2005-09-30 B Purchase THACHUK E DEL

CEO and President

Executive Director
100,000 +inf%
0.05
US$5,000 		100,000 +inf% 0.05 US$5,000
2005-11-23 2005-09-30 B Purchase Brooke Brian Gordon

Chief Financial Officer

Executive Director
50,000 +inf%
0.05
US$2,500 		50,000 +inf% 0.05 US$2,500
Explore more

More insider trading research around VolitionRX Ltd

More insider trades in United States
Insider trading in North America